Sponsor Pipeline

Tasly Biopharmaceuticals Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
1
Recruiting
10
Disease Areas
Active Trials by Phase
Phase 2
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06724263 A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of… Recurrent Platinum-resistant Epithelial Ovarian Cancer Not Yet Recruiting
NCT06838546 A Multicenter, Open Phase IIb Clinical Study to Evaluate the Efficacy and Safety of B1962… Advanced Colorectal Cancer Not Yet Recruiting
Phase 1
NCT07128797 a Safety, Tolerability, and Pharmacokinetic Trial of Multiple Subcutaneous Injections of… NAFLD (Non-alcoholic Fatty Liver Disease) Recruiting
Disease Areas
Get alerts when Tasly Biopharmaceuticals Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free